Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're already taking amlodipine for high blood pressure or angina and you've been considering tirzepatide (Mounjaro) for weight management, the good news is that no clinically significant pharmacokinetic interaction between the two medicines has been identified. Amlodipine is a calcium channel blocker that works on your blood vessels; Mounjaro is a dual GIP and GLP-1 receptor agonist that acts primarily on appetite and blood-sugar regulation. Their mechanisms don't directly clash. That said, combining any blood-pressure medicine with a treatment that can itself nudge blood pressure downward through weight loss deserves a proper clinical look before you start. These are prescription-only medicines, and a prescriber who knows your full picture is the right person to assess them together.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a situation a lot of people find themselves in. Amlodipine is one of the most widely prescribed medicines in the UK, it's a first-line choice for high blood pressure and some forms of angina, and many people take it for years without thinking much about it. When a new treatment enters the picture, the natural question is whether the two can coexist without problems.
Looking at how each medicine works makes this easier to think through. Amlodipine blocks calcium channels in the walls of your blood vessels, causing them to relax and widen, which reduces the force your heart has to pump against. Tirzepatide (the active ingredient in Mounjaro) acts on GIP and GLP-1 receptors in the gut and brain, reducing appetite and slowing the rate at which food leaves your stomach. These are entirely different pathways, and the Mounjaro SmPC (the full prescribing information reviewed by the MHRA) does not flag amlodipine as a medicine with a clinically significant direct interaction. The NHS tirzepatide medicines page is a useful starting point if you want a plain-English summary of what is and isn't known about Mounjaro's interactions more broadly.
Worth clearing up one common assumption: some people expect that because both medicines can affect cardiovascular function, taking them together must be risky. In practice, the concern runs the other way, it's about monitoring rather than avoidance.
Here's where the practical conversation gets more interesting. Mounjaro doesn't lower blood pressure directly in the way amlodipine does, but significant weight loss (the kind that the tirzepatide clinical evidence consistently shows) tends to bring blood pressure down as a secondary effect. Fat tissue, particularly around the abdomen, contributes to vascular resistance; less of it usually means a lower reading over time.
If you're already taking amlodipine and your blood pressure is well controlled, meaningful weight loss could push your readings lower than your prescriber intended. For most people that's not an emergency, but it's not something to ignore either. Symptoms of blood pressure that has dropped too far include lightheadedness when you stand up, unusual tiredness, or feeling faint, none of which you should write off as just a side effect of Mounjaro. Your GP or prescriber should know that you're on both treatments so they can monitor your readings and adjust your amlodipine if the time comes. This is one of the reasons Mounjaro's clinical management involves regular review rather than a one-off prescription.
If you'd like to understand more about how Mounjaro affects the body more broadly, including some of the less-discussed effects, this page on Mounjaro and urine changes and our guide to joint discomfort on Mounjaro cover aspects that often come up once treatment is underway.
Both amlodipine and Mounjaro can, in some people, cause ankle swelling, dizziness, and fatigue. Amlodipine-related ankle oedema is fairly well recognised and often more pronounced in the early weeks of treatment or after a dose increase. Mounjaro's side effects tend to be gastrointestinal (nausea, loose stools, and reduced appetite are the most common) but dizziness and tiredness appear on its list too, particularly around dose-escalation periods.
If you develop ankle swelling or feel dizzy after starting Mounjaro alongside amlodipine, resist the urge to assume it's one or the other and adjust anything yourself. Tell your prescriber, describe when it started relative to any dose changes, and let them work through it. Trying to manage overlapping side effects from two medicines without that input is how small problems get complicated.
For context on how Mounjaro sits alongside other common medicines, our pages on Mounjaro and mirtazapine and carbamazepine and Mounjaro cover similarly common combinations where the nuances matter. If lifestyle questions are also on your mind, the Mounjaro and alcohol page addresses something our prescribers are asked about regularly.
The short answer to "can you take Mounjaro with amlodipine" is: for most people it's clinically manageable, but it requires proper assessment and monitoring, not a quick online tick-box. Your prescriber needs to know about amlodipine (and everything else you take) before approving treatment.
At nume, every consultation is read the same day by a GPhC-registered Independent Prescriber who looks at your full medication list, your blood pressure history, and your overall health picture. If Mounjaro is appropriate, they'll say so; if your cardiovascular history or current readings give reason for caution, they'll tell you that too. Once treatment starts, we review clinically before every repeat order, so if your blood pressure is changing because the treatment is working, that's something we pick up rather than something you have to chase. You can also find a broader overview of weight-loss treatment options and what the assessment involves if you're still weighing things up. For questions about what private treatment costs and what's included, our Mounjaro pricing page sets out exactly what one transparent price covers.
If you'd like a prescriber to assess whether Mounjaro is right for you alongside amlodipine, speak to our prescribers through a free consultation, no referral required, and your current medicines are part of every review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.